Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
237 hedge funds and large institutions have $3.87B invested in Arena Pharmaceuticals Inc in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 82 increasing their positions, 71 reducing their positions, and 35 closing their positions.
107% more call options, than puts
Call options by funds: $30.5M | Put options by funds: $14.7M
15% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 71
9% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 35
1% more funds holding
Funds holding: 235 → 237 (+2)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
1% less capital invested
Capital invested by funds: $3.89B → $3.87B (-$22.7M)
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$57.4M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$27.4M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$24.4M |
| 4 |
Holocene Advisors
New York
|
+$24.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$23.5M |
Top Sellers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$57M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$46.6M |
| 3 |
PA
Perceptive Advisors
New York
|
-$39.9M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$27.4M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$19.8M |
ARNA Hedge Fund Activity: Q2 2021 in Review
237 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2021, worth a combined $3.87B — down 0.58% from $3.89B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ARNA positions and 35 closed out — a net gain of 3 holders — while 82 added to existing stakes and 71 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $57.4M. The largest seller was AllianceBernstein, cutting an estimated $57M.
- 237 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2021, up from 235 in Q1 2021.
- Funds reported $3.87B of Arena Pharmaceuticals Inc stock for Q2 2021, down 0.58% quarter-over-quarter.
- 38 funds opened new Arena Pharmaceuticals Inc positions in Q2 2021 and 35 closed out, a net change of +3 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q2 2021 was JP Morgan Chase, an estimated $57.4M added.
- The largest Arena Pharmaceuticals Inc seller in Q2 2021 was AllianceBernstein, an estimated $57M sold.
Based on aggregated 13F filings for Q2 2021.